Monday January 27, 2020

What price a cure?

The number of hugely expensive drugs to treat rare diseases is increasing but can we afford them?

Susan Mitchell

Deputy Editor and Health Editor

@susmitchellsbp
6th December, 2015

Martin Shkreli recently gained widespread opprobrium when his company raised the price of Daraprim, a 62-year-old old drug used to treat Aids patients, by 5,000 per cent to more than $750 a pill.

The pricing strategy by Shkreli’s Turing Pharmaceuticals infuriated the public. Suddenly, pharmaceutical pricing entered the presidential debate in the US.

Billionaire Donald Trump, the Republican presidential frontrunner, called Shkreli a “spoiled brat”, while Democratic frontrunner Hillary Clinton tweeted about it as a...

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader

Trial

€1

Unlimited Access for 1 Month

Then €19.99 a month after the offer period.

Get basic
*New subscribers only
You can cancel any time.

Annual

€200

€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.

Quarterly

€55

€42

90 Day Pass

You can cancel any time.

Team Pass

Get a Business Account for you and your team

Share this post

Related Stories

The genetic data harvesting company posted the results as calls were made for the Irish government to appoint a genomics medicine guru

Killian Woods | 1 day ago

The HSE has a funding crisis. Unless it is solved, the Sláintecare health reform programme cannot be implemented

Tony O'Brien | 1 day ago

As we celebrate the year of the International Year of the Nurse and Midwife, Susan Kent explores Florence Nightingale’s impact on healthcare – and the lessons modern Irish health policy could take from her approach

Susan Kent | 1 day ago